EV/EBITDA Ratio: 12.24x
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 12.24x is 47% below its 5-year average of 22.90x, near the low end of its 5-year range (11.63x–38.87x).
As of Friday, June 26, 2026. 29.29% below its 12-month average of 17.31x.
STE EV/EBITDA Ratio Chart
STE Average EV/EBITDA Ratio Chart
STE Current vs Average EV/EBITDA Ratio Chart
STE EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
12.24x
EV/EBITDA RATIO AVG TTM
17.31x
EV/EBITDA RATIO AVG 3Y
17.67x
EV/EBITDA RATIO AVG 5Y
22.90x
EV/EBITDA RATIO AVG 10Y
19.79x
EV/EBITDA RATIO AVG 15Y
16.91x
EV/EBITDA RATIO AVG 20Y
15.35x
CURRENT VS TTM AVG
-29.29%
CURRENT VS 3Y AVG
-30.71%
CURRENT VS 5Y AVG
-46.55%
CURRENT VS 10Y AVG
-38.15%
CURRENT VS 15Y AVG
-27.61%
CURRENT VS 20Y AVG
-20.25%
STE Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $20.52B | 12.24x | 17.31x | 17.67x | 22.90x |
| Incyte Corporation (INCY)vs › | $21.48B | 10.06x | 11.95x | 18.06x | 20.18x |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 13.73x | 14.62x | 14.58x | 11.77x |
| Viatris Inc. (VTRS)vs › | $18.71B | 12.25x | 12.34x | 8.53x | 8.66x |
| BioNTech SE (BNTX)vs › | $22.76B | N/A | 51.40x | 19.63x | 20.05x |
| Quest Diagnostics Incorporated (DGX)vs › | $22.83B | 13.98x | 12.92x | 12.65x | 10.85x |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | 14.34x | 11.79x | 10.13x | 11.30x |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.60B | 11.27x | 11.09x | 13.13x | 15.70x |
| Moderna, Inc. (MRNA)vs › | $23.71B | N/A | 12.39x | 25.28x | 25.28x |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.28x | 15.01x | 15.35x | 12.41x |
EV/EBITDA vs. its own history
At 12.2, EV/EBITDA is in its normal range, sitting higher than 36% of its 20-year history.
20-year low
5.1
median
15.9
20-year high
38.9
EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for STERIS plc (STE)?
- The EV/EBITDA ratio for STE stock is 12.24x.
- Is STERIS plc's EV/EBITDA ratio high or low?
- The EV/EBITDA ratio of 12.24x is 47% below its 5-year average of 22.90x, near the low end of its 5-year range (11.63x–38.87x).
- What is the TTM average EV/EBITDA ratio for STERIS plc (STE)?
- The TTM average EV/EBITDA ratio for STE stock is 17.31x.
- What is the 3Y average EV/EBITDA ratio for STERIS plc (STE)?
- The 3Y average EV/EBITDA ratio for STE stock is 17.67x.
- What is the 5Y average EV/EBITDA ratio for STERIS plc (STE)?
- The 5Y average EV/EBITDA ratio for STE stock is 22.90x.
- What is the 10Y average EV/EBITDA ratio for STERIS plc (STE)?
- The 10Y average EV/EBITDA ratio for STE stock is 19.79x.
- What is the 15Y average EV/EBITDA ratio for STERIS plc (STE)?
- The 15Y average EV/EBITDA ratio for STE stock is 16.91x.
- What is the 20Y average EV/EBITDA ratio for STERIS plc (STE)?
- The 20Y average EV/EBITDA ratio for STE stock is 15.35x.
STE EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-25 | 12.24x |
| 2026-06-24 | 12.05x |
| 2026-06-23 | 11.84x |
| 2026-06-22 | 11.69x |
| 2026-06-18 | 11.81x |
| 2026-06-17 | 11.63x |
| 2026-06-16 | 12.02x |
| 2026-06-15 | 11.99x |
| 2026-06-12 | 12.07x |
| 2026-06-11 | 12.05x |
| 2026-06-10 | 12.10x |
| 2026-06-09 | 12.36x |
| 2026-06-08 | 12.21x |
| 2026-06-05 | 12.33x |
| 2026-06-04 | 12.32x |
| 2026-06-03 | 12.21x |
| 2026-06-02 | 12.19x |
| 2026-06-01 | 12.26x |
| 2026-05-29 | 12.35x |
| 2026-05-28 | 15.43x |
| 2026-05-27 | 15.26x |
| 2026-05-26 | 15.49x |
| 2026-05-22 | 15.51x |
| 2026-05-21 | 15.71x |
| 2026-05-20 | 15.47x |
| 2026-05-19 | 15.36x |
| 2026-05-18 | 15.26x |
| 2026-05-15 | 15.21x |
| 2026-05-14 | 15.47x |
| 2026-05-13 | 15.14x |
| 2026-05-12 | 15.13x |
| 2026-05-11 | 14.53x |
| 2026-05-08 | 14.90x |
| 2026-05-07 | 15.32x |
| 2026-05-06 | 15.37x |
| 2026-05-05 | 15.27x |
| 2026-05-04 | 15.22x |
| 2026-05-01 | 15.36x |
| 2026-04-30 | 15.53x |
| 2026-04-29 | 15.25x |
| 2026-04-28 | 15.72x |
| 2026-04-27 | 15.88x |
| 2026-04-24 | 15.86x |
| 2026-04-23 | 15.97x |
| 2026-04-22 | 15.97x |
| 2026-04-21 | 15.70x |
| 2026-04-20 | 16.16x |
| 2026-04-17 | 16.12x |
| 2026-04-16 | 15.73x |
| 2026-04-15 | 15.84x |
| 2026-04-14 | 16.06x |
| 2026-04-13 | 16.06x |
| 2026-04-10 | 15.91x |
| 2026-04-09 | 15.99x |
| 2026-04-08 | 16.07x |
| 2026-04-07 | 15.68x |
| 2026-04-06 | 15.73x |
| 2026-04-02 | 15.65x |
| 2026-04-01 | 15.73x |
| 2026-03-31 | 15.81x |
| 2026-03-30 | 15.69x |
| 2026-03-27 | 15.70x |
| 2026-03-26 | 15.96x |
| 2026-03-25 | 15.96x |
| 2026-03-24 | 15.85x |
| 2026-03-23 | 15.80x |
| 2026-03-20 | 15.74x |
| 2026-03-19 | 15.60x |
| 2026-03-18 | 15.48x |
| 2026-03-17 | 15.74x |
| 2026-03-16 | 15.67x |
| 2026-03-13 | 15.37x |
| 2026-03-12 | 15.23x |
| 2026-03-11 | 15.84x |
| 2026-03-10 | 15.87x |
| 2026-03-09 | 16.25x |
| 2026-03-06 | 16.44x |
| 2026-03-05 | 16.97x |
| 2026-03-04 | 17.27x |
| 2026-03-03 | 17.29x |
| 2026-03-02 | 17.58x |
| 2026-02-27 | 17.89x |
| 2026-02-26 | 18.04x |
| 2026-02-25 | 17.84x |
| 2026-02-24 | 17.52x |
| 2026-02-23 | 17.54x |
| 2026-02-20 | 17.78x |
| 2026-02-19 | 17.81x |
| 2026-02-18 | 17.69x |
| 2026-02-17 | 17.43x |
| 2026-02-13 | 17.62x |
| 2026-02-12 | 17.35x |
| 2026-02-11 | 17.30x |
| 2026-02-10 | 17.38x |
| 2026-02-09 | 17.43x |
| 2026-02-06 | 17.88x |
| 2026-02-05 | 17.60x |
| 2026-02-04 | 18.98x |
| 2026-02-03 | 18.80x |
| 2026-02-02 | 18.98x |
| 2026-01-30 | 18.87x |
| 2026-01-29 | 18.80x |
| 2026-01-28 | 18.75x |
| 2026-01-27 | 18.90x |
| 2026-01-26 | 18.90x |
| 2026-01-23 | 18.66x |
| 2026-01-22 | 18.75x |
| 2026-01-21 | 18.77x |
| 2026-01-20 | 18.56x |
| 2026-01-16 | 19.27x |
| 2026-01-15 | 19.25x |
| 2026-01-14 | 18.98x |
| 2026-01-13 | 18.68x |
| 2026-01-12 | 18.74x |
| 2026-01-09 | 18.48x |
| 2026-01-08 | 18.74x |
| 2026-01-07 | 18.64x |
| 2026-01-06 | 18.69x |
| 2026-01-05 | 18.47x |
| 2026-01-02 | 18.02x |
| 2025-12-31 | 18.25x |
| 2025-12-30 | 18.39x |
| 2025-12-29 | 18.44x |
| 2025-12-26 | 18.38x |
| 2025-12-24 | 18.40x |
| 2025-12-23 | 18.38x |
| 2025-12-22 | 18.36x |
| 2025-12-19 | 18.31x |
| 2025-12-18 | 18.12x |
| 2025-12-17 | 18.13x |
| 2025-12-16 | 18.22x |
| 2025-12-15 | 18.29x |
| 2025-12-12 | 18.14x |
| 2025-12-11 | 18.19x |
| 2025-12-10 | 18.61x |
| 2025-12-09 | 18.51x |
| 2025-12-08 | 18.79x |
| 2025-12-05 | 18.91x |
| 2025-12-04 | 18.76x |
| 2025-12-03 | 18.65x |
| 2025-12-02 | 18.64x |
| 2025-12-01 | 18.89x |
| 2025-11-28 | 19.11x |
| 2025-11-26 | 19.15x |
| 2025-11-25 | 19.22x |
| 2025-11-24 | 18.90x |
| 2025-11-21 | 18.91x |
| 2025-11-20 | 18.49x |
| 2025-11-19 | 18.33x |
| 2025-11-18 | 18.49x |
| 2025-11-17 | 18.49x |
| 2025-11-14 | 18.58x |
| 2025-11-13 | 18.72x |
| 2025-11-12 | 19.23x |
| 2025-11-11 | 19.14x |
| 2025-11-10 | 18.96x |
| 2025-11-07 | 18.94x |
| 2025-11-06 | 18.69x |
| 2025-11-05 | 18.34x |
| 2025-11-04 | 18.25x |
| 2025-11-03 | 17.93x |
| 2025-10-31 | 17.82x |
| 2025-10-30 | 17.85x |
| 2025-10-29 | 17.89x |
| 2025-10-28 | 18.20x |
| 2025-10-27 | 18.18x |
| 2025-10-24 | 18.17x |
| 2025-10-23 | 18.25x |
| 2025-10-22 | 18.28x |
| 2025-10-21 | 18.26x |
| 2025-10-20 | 18.27x |
| 2025-10-17 | 18.13x |
| 2025-10-16 | 18.14x |
| 2025-10-15 | 17.89x |
| 2025-10-14 | 17.96x |
| 2025-10-13 | 17.80x |
| 2025-10-10 | 17.82x |
| 2025-10-09 | 18.08x |
| 2025-10-08 | 18.28x |
| 2025-10-07 | 18.23x |
| 2025-10-06 | 18.16x |
| 2025-10-03 | 18.29x |
| 2025-10-02 | 18.29x |
| 2025-10-01 | 18.21x |
| 2025-09-30 | 18.64x |
| 2025-09-29 | 18.49x |
| 2025-09-26 | 18.75x |
| 2025-09-25 | 18.41x |
| 2025-09-24 | 18.54x |
| 2025-09-23 | 18.77x |
| 2025-09-22 | 18.80x |
| 2025-09-19 | 18.73x |
| 2025-09-18 | 18.85x |
| 2025-09-17 | 18.73x |
| 2025-09-16 | 18.68x |
| 2025-09-15 | 18.67x |
| 2025-09-12 | 18.81x |
| 2025-09-11 | 18.99x |
| 2025-09-10 | 18.39x |
| 2025-09-09 | 18.71x |
| 2025-09-08 | 18.70x |
| 2025-09-05 | 18.49x |
| 2025-09-04 | 18.36x |
| 2025-09-03 | 18.29x |
| 2025-09-02 | 18.26x |
| 2025-08-29 | 18.47x |
| 2025-08-28 | 18.45x |
| 2025-08-27 | 18.75x |
| 2025-08-26 | 18.72x |
| 2025-08-25 | 18.71x |
| 2025-08-22 | 18.95x |
| 2025-08-21 | 18.64x |
| 2025-08-20 | 18.79x |
| 2025-08-19 | 18.65x |
| 2025-08-18 | 18.44x |
| 2025-08-15 | 18.51x |
| 2025-08-14 | 18.55x |
| 2025-08-13 | 18.61x |
| 2025-08-12 | 18.38x |
| 2025-08-11 | 18.23x |
| 2025-08-08 | 18.32x |
| 2025-08-07 | 17.85x |
| 2025-08-06 | 17.57x |
| 2025-08-05 | 17.77x |
| 2025-08-04 | 18.10x |
| 2025-08-01 | 17.99x |
| 2025-07-31 | 17.96x |
| 2025-07-30 | 18.16x |
| 2025-07-29 | 18.09x |
| 2025-07-28 | 17.96x |
| 2025-07-25 | 18.25x |
| 2025-07-24 | 18.01x |
| 2025-07-23 | 17.88x |
| 2025-07-22 | 17.75x |
| 2025-07-21 | 17.68x |
| 2025-07-18 | 17.89x |
| 2025-07-17 | 17.82x |
| 2025-07-16 | 18.04x |
| 2025-07-15 | 18.13x |
| 2025-07-14 | 17.91x |
| 2025-07-11 | 18.07x |
| 2025-07-10 | 18.27x |
| 2025-07-09 | 18.31x |
| 2025-07-08 | 18.40x |
| 2025-07-07 | 18.45x |
| 2025-07-03 | 18.76x |
| 2025-07-02 | 18.81x |
| 2025-07-01 | 19.13x |
| 2025-06-30 | 18.96x |
| 2025-06-27 | 18.85x |
| 2025-06-26 | 18.83x |
| 2025-06-25 | 18.97x |
| 2025-06-24 | 18.91x |
| 2025-06-23 | 18.72x |
| 2025-06-20 | 18.62x |
| 2025-06-18 | 18.67x |
| 2025-06-17 | 18.73x |
| 2025-06-16 | 19.02x |
| 2025-06-13 | 19.04x |
| 2025-06-12 | 19.11x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Daniel A. Carestio